The Masimo trial ultimately failed to get a permanent ban on Apple Watch sales or use of the blood oxygen sensor, but the ...
Apple’s requests to overturn a $634 million patent verdict and secure a new trial in its long-running legal battle with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The company, in its first-quarter earnings call, said it was seeing 30% year-over-year growth in equipment orders, the first sign of a multiyear manufacturing investment cycle, helped along by ...
Speciality diagnostics solutions developer Masimo has received 510(k) clearance from the US Food and Drug Administration (FDA) for an opioid-induced respiratory depression (OIRD) detection feature ...
Hosted on MSN
Danaher is down 22% this year. Is the Masimo acquisition the entry point investors have been waiting for?
The company is seeing a big uptick in equipment orders. Danaher said it expects its acquisition of Masimo to be accretive to earnings this year. The life sciences industry has slowed since its ...
The WSJ/College Pulse 2025 Best Colleges in the U.S. ranking rates the top 500 universities in the country. The ranking was developed and executed in collaboration with our research partners College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results